Seeking Alpha

Allergan (AGN -9.4%) dives as management - on today's earnings call - has less than great...

Allergan (AGN -9.4%) dives as management - on today's earnings call - has less than great progress to report on a couple of drugs in development. Regeneron (REGN +12.4%) spikes higher.
Comments (1)
  • lucagrs
    , contributor
    Comments (68) | Send Message
     
    Too bad the CEO sold 80,000 shares on this day, if only he had waited two days more he could have made $1.6 mln more.
    4 May 2013, 10:10 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs